134 related articles for article (PubMed ID: 31784278)
1. Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure.
Palese F; Bonomi E; Nuzzo T; Benussi A; Mellone M; Zianni E; Cisani F; Casamassa A; Alberici A; Scheggia D; Padovani A; Marcello E; Di Luca M; Pittaluga A; Usiello A; Borroni B; Gardoni F
Neurobiol Aging; 2020 Feb; 86():143-155. PubMed ID: 31784278
[TBL] [Abstract][Full Text] [Related]
2. Anti-AMPA GluA3 antibodies in Frontotemporal dementia: a new molecular target.
Borroni B; Stanic J; Verpelli C; Mellone M; Bonomi E; Alberici A; Bernasconi P; Culotta L; Zianni E; Archetti S; Manes M; Gazzina S; Ghidoni R; Benussi L; Stuani C; Di Luca M; Sala C; Buratti E; Padovani A; Gardoni F
Sci Rep; 2017 Jul; 7(1):6723. PubMed ID: 28751743
[TBL] [Abstract][Full Text] [Related]
3. Toward a Glutamate Hypothesis of Frontotemporal Dementia.
Benussi A; Alberici A; Buratti E; Ghidoni R; Gardoni F; Di Luca M; Padovani A; Borroni B
Front Neurosci; 2019; 13():304. PubMed ID: 30983965
[TBL] [Abstract][Full Text] [Related]
4. GluA3 autoantibodies induce alterations in dendritic spine and behavior in mice.
Scheggia D; Stanic J; Italia M; La Greca F; Zianni E; Benussi A; Borroni B; Di Luca M; Gardoni F
Brain Behav Immun; 2021 Oct; 97():89-101. PubMed ID: 34246733
[TBL] [Abstract][Full Text] [Related]
5. NMDA and AMPA Receptor Autoantibodies in Brain Disorders: From Molecular Mechanisms to Clinical Features.
Gardoni F; Stanic J; Scheggia D; Benussi A; Borroni B; Di Luca M
Cells; 2021 Jan; 10(1):. PubMed ID: 33466431
[TBL] [Abstract][Full Text] [Related]
6. Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg?
Cavazzana I; Alberici A; Bonomi E; Ottaviani R; Kumar R; Archetti S; Manes M; Cosseddu M; Buratti E; Padovani A; Tincani A; Franceschini F; Borroni B
J Neuroimmunol; 2018 Dec; 325():61-63. PubMed ID: 30391902
[TBL] [Abstract][Full Text] [Related]
7. Autoimmunity and Frontotemporal Dementia.
Alberici A; Cristillo V; Gazzina S; Benussi A; Padovani A; Borroni B
Curr Alzheimer Res; 2018; 15(7):602-609. PubMed ID: 29357796
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiological aspects of frontotemporal dementia--emphasis on cytoskeleton proteins and autoimmunity.
Sjögren M; Wallin A
Mech Ageing Dev; 2001 Nov; 122(16):1923-35. PubMed ID: 11589911
[TBL] [Abstract][Full Text] [Related]
9. Metabotropic glutamate receptors modulate glutamatergic and GABAergic synaptic transmission in the central nucleus of the inferior colliculus.
Farazifard R; Wu SH
Brain Res; 2010 Apr; 1325():28-40. PubMed ID: 20153735
[TBL] [Abstract][Full Text] [Related]
10. Relevance of raised cerebrospinal fluid monocyte levels in patients with frontotemporal dementia.
Pawlowski M; Lueg G; Gross CC; Johnen A; Krämer J; Weckesser M; Wiendl H; Meuth SG; Duning T
Neurobiol Aging; 2018 Feb; 62():45-52. PubMed ID: 29107846
[TBL] [Abstract][Full Text] [Related]
11. Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease.
Goetzl EJ; Kapogiannis D; Schwartz JB; Lobach IV; Goetzl L; Abner EL; Jicha GA; Karydas AM; Boxer A; Miller BL
FASEB J; 2016 Dec; 30(12):4141-4148. PubMed ID: 27601437
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune Frontotemporal Dementia: A New Nosological Entity?
Borroni B; Manes MA; Alberici A; Cosseddu M; Bernasconi P; Archetti S; Pinelli L; Gasparotti R; Padovani A
Alzheimer Dis Assoc Disord; 2017; 31(3):259-262. PubMed ID: 28338508
[No Abstract] [Full Text] [Related]
13. Aspartate and glutamate mediate excitatory synaptic transmission in area CA1 of the hippocampus.
Fleck MW; Henze DA; Barrionuevo G; Palmer AM
J Neurosci; 1993 Sep; 13(9):3944-55. PubMed ID: 7690067
[TBL] [Abstract][Full Text] [Related]
14. Synaptic plasticity through activation of GluA3-containing AMPA-receptors.
Renner MC; Albers EH; Gutierrez-Castellanos N; Reinders NR; van Huijstee AN; Xiong H; Lodder TR; Kessels HW
Elife; 2017 Aug; 6():. PubMed ID: 28762944
[TBL] [Abstract][Full Text] [Related]
15. Molecular and anatomical evidence for the input pathway- and target cell type-dependent regulation of glutamatergic synapses.
Yamasaki M
Anat Sci Int; 2016 Jan; 91(1):8-21. PubMed ID: 26439731
[TBL] [Abstract][Full Text] [Related]
16. Impaired auditory processing and altered structure of the endbulb of Held synapse in mice lacking the GluA3 subunit of AMPA receptors.
García-Hernández S; Abe M; Sakimura K; Rubio ME
Hear Res; 2017 Feb; 344():284-294. PubMed ID: 28011083
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
[TBL] [Abstract][Full Text] [Related]
18. Neuroinflammation in frontotemporal dementia.
Bright F; Werry EL; Dobson-Stone C; Piguet O; Ittner LM; Halliday GM; Hodges JR; Kiernan MC; Loy CT; Kassiou M; Kril JJ
Nat Rev Neurol; 2019 Sep; 15(9):540-555. PubMed ID: 31324897
[TBL] [Abstract][Full Text] [Related]
19. Oxytocin suppresses basal glutamatergic transmission but facilitates activity-dependent synaptic potentiation in the medial prefrontal cortex.
Ninan I
J Neurochem; 2011 Oct; 119(2):324-31. PubMed ID: 21848811
[TBL] [Abstract][Full Text] [Related]
20. Increasing binding affinity of agonists to glutamate receptors increases synaptic responses at glutamatergic synapses.
Shahi K; Baudry M
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6881-5. PubMed ID: 1379724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
